Silvia Schenone

Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment

F. Musumeci, Davide Frumento, Giancarlo Grossi, 2024, International journal of molecular sciences.

State-of-the-art Review on the Antiparasitic Activity of Benzimidazole-based Derivatives: Facing Malaria, Leishmaniasis, and Trypanosomiasis

M. Tonelli, Valeria Francesconi, Anna Carbone, 2023, Current medicinal chemistry.

Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment

G. Damonte, F. Musumeci, E. Dreassi, 2024, Drug development research (Print).

New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL Agonists

F. Musumeci, L. Sturla, E. Zocchi, 2023, Pharmaceutics.

Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA–PB1 Subunits Interaction

F. Musumeci, A. Loregian, Chiara Bertagnin, 2024, Pharmaceutics.